Integral Health Asset Management’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
2024
Q4
$7.12M Buy
2024
Q3
$11.6M Buy
2024
Q2
$3.88M Buy
2024
Q1
$2.65M Buy
2023
Q3
Sell
2023
Q2
$2.09M Buy
2023
Q1
$2.13M Sell
2022
Q4
$2.88M Buy
2022
Q2
Sell
2022
Q1
$4.41M Buy
2021
Q4
$2.05M Buy